SCHEMBL7947783

SCHEMBL7947783

CCOC(=O)/C=C/c1ccc(N(C)C(=O)OC(C)(C)C)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
TTR P02766 1/20 0.45
DPP4 P27487 1/20 0.45
CYP3A4 P08684 2/20 0.43
FDPS P14324 1/20 0.43
MAOB P27338 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
POLB P06746 1/20 0.40
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39
P2RY12 Q9H244 1/20 0.38
ALOX5 P09917 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6431897 1.00 CA12 (0.48) CA12CA1CA2CA7CA9
SCHEMBL721862 0.89 CA12 (0.49) CA12CA1CA2CA7CA9
SCHEMBL19304337 0.85 P4HTM (0.47) CA12CA1CA2CA7CA9
SCHEMBL22420504 0.83 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL19304323 0.83 CA12 (0.43) CA12CA1CA2CA7CA9
SCHEMBL21591548 0.82 CA12 (0.57) CA12CA1CA2CA7CA9
SCHEMBL19304338 0.81 TTK (0.34) NPC1RAB9AMAPT
SCHEMBL29962184 0.81 MIF (0.39) CA12CA1CA2CA7CA9
SCHEMBL1579324 0.79 CA12 (0.54) CA12CA1CA2CA7CA9
SCHEMBL6177591 0.79 TTK (0.35) NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017146128-A1 IMIDAZOLYLAMIDE DERIVATIVE 大日本住友製薬株式会社 2017-08-31 WO disclosed
US-6268378-B1 TREATING AND PREVENTING OSTEOPOROSIS, AND INHIBITING VASCULAR RESTENOSIS, DIABETIC RETINOPATHY, MACULAR DEGENERATION, ANGIOGENESIS, ATHEROSCLEROSIS, INFLAMMATION, VIRAL DISEASE, AND TUMOR GROWTH. MERCK & CO., INC. 2001-07-31 US disclosed
US-6066648-A USEFUL IN INHIBITING BONE RESORPTION, TREATING AND PREVENTING OSTEOPOROSIS, AND INHIBITING VASCULAR RESTENOSIS, DIABETIC RETINOPATHY, MACULAR DEGENERATION, ANGIOGENESIS, ATHEROSCLEROSIS, INFLAMMATION, VIRAL DISEASE, AND TUMOR GROWTH MERCK & CO., INC. (US) 2000-05-23 US disclosed
US-6017926-A Integrin receptor antagonists MERCK & CO., INC. (US) 2000-01-25 US disclosed